$0.00
+0.00 (+100.00%)
Open$0.00
Previous Close$0.00
Day High$0.00
Day Low$0.00
52W High$1.67
52W Low—
Volume—
Avg Volume41.0K
Market Cap223.0K
P/E Ratio—
EPS$-1.34
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 16.46M | 14.50M | 15.97M |
| Net Income | 527.9K | 404.7K | 468.6K |
| Profit Margin | 3.2% | 2.8% | 2.9% |
| EBITDA | 822.7K | 875.9K | 889.3K |
| Free Cash Flow | 305.6K | 207.6K | 283.2K |
| Rev Growth | +9.2% | +19.8% | +5.1% |
| Debt/Equity | 1.41 | 1.41 | 1.44 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |